Tyrosinase inhibitors are candidates for skin-whitening agents that are useful in cosmetics to counteract age-related skin hyperpigmentation, and they also have potential in the treatment of diseases associated with tyrosinase misregulated expression and/or activity, such as urticaria pigmentosa [6]. Here, TYR is linked to maculopapular cutaneous mastocytosis.